University of South Florida

First Voice AI Symposium hosted in Washington DC

Voice and artificial intelligence experts gathered at the inaugural Voice AI Symposium held in Washington DC last month to share insight and safeguards for the use of voice as a biomarker for health. The one-day interactive event brought together experts in the field of voice biomarkers, including industry, startups, academia, researchers, patients, patient advocacy groups and underserved and underrepresented communities. These experts presented research and discussed the impact voice can have on treating diseases as varied as lung cancer, Parkinson’s disease, heart disease, and mental health.

The Voice AI Symposium was a unique, first-of-its-kind gathering of experts across industries to explore the impact voice can have on health care and was hosted by Bridge2AI-Voice Consortium, a program based on the NIH-funded study called Voice as a Biomarker of Health that is co-led by Dr Yaël Bensoussan, MD, from USF Health Morsani College of Medicine and Olivier Elemento, PhD from Weill Cornell Medicine, who are co-principal investigators for the project.

Dr. Yaël Bensoussan and Dr. Olivier Elemento.

Learn more about the Voice AI Symposium — more…

Photos by Peter Cleary, Weill Cornell College of Medicine.

Network-wide options by YD - Freelance Wordpress Developer